Genese Technology Corporation, the company that makes the MRNA robot that was featured in the recent episode of the US show Silicon Valley, is planning to raise a further £1bn in funding.
The investment will be made through a private placement fund, which will be chaired by the Genesesee board, Genesse said in a statement.
“We are proud to announce that the funding we have raised over the last two years is going to support the development of our new generation of robots that can be used by our customers in the future,” said Geneesee CEO, David Wills.
“This funding will allow us to accelerate our efforts to further accelerate the growth of robotics and enable us to deliver robots that people want and need.”
Genesee Technology Corp., which has a $2bn annual revenue base, has made robotics its focus in recent years and has developed robots to help people with disabilities in the past.
The company’s latest robot, the MRN-1, was created by a team of scientists and engineers led by Mark Bensky and Peter Kuzminski, both from the University of Pennsylvania.
The MRN robot can move up to 20 times its own weight, but it has been built to move up and down stairs, climb and crawl.
In the episode, the pair demonstrate the robot’s ability to pick up a piece of paper, lift it off the floor, and then put it in a basket.
The robots ability to walk, pick up objects and even climb walls was highlighted by the show’s creator, Kevin Smith.
But Genesue Technology Corp said the robot has also been used by other businesses including a hotel and food delivery company, and is currently used by some of the world’s biggest organisations, including the World Bank, the International Monetary Fund, and the United Nations.
The firm said it was not commenting further on the funding announcement at this time.